Skip to main content
A Singapore Government Agency Website How to identify
Official website links end with .gov.sg
Secure websites use HTTPS
Look for a lock () or https:// as an added precaution. Share sensitive information only on official, secure websites.
Government officials will never ask you to transfer money or disclose bank log-in details over a phone call.

Call the 24/7 ScamShield Helpline at 1799 if you are unsure if something is a scam.

National Drug Formulary

GANFORT PF EYE DROPS (BIMATOPROST 0.3MG/ML, TIMOLOL 5.0MG/ML) [SIN14966P]

Active ingredients: BIMATOPROST | TIMOLOL MALEATE 6.8 MG/ML EQV TIMOLOL

View product's general information
Last updated on 9 October 2026

Product Info

GANFORT PF EYE DROPS (BIMATOPROST 0.3MG/ML, TIMOLOL 5.0MG/ML)

[SIN14966P]

Product information

Active Ingredient and Strength

BIMATOPROST - 0.3 MG/ML
TIMOLOL MALEATE 6.8 MG/ML EQV TIMOLOL - 5 MG/ML

Dosage Form

SOLUTION, STERILE

Manufacturer and Country

ALLERGAN PHARMACEUTICALS IRELAND - IRELAND

Registration Number

SIN14966P

Licence Holder

ABBVIE PTE. LTD.

Forensic Classification

PRESCRIPTION ONLY MEDICINES

Anatomical Therapeutic Chemical (ATC) code

S01ED51

Prescription-only Medicines with Exemptions for Supply without Prescription

NA

Indication

INDICATIONS

GANFORT® PF eye drops are indicated for the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues.

Dosing

DOSAGE AND ADMINISTRATION

The recommended dose is one drop of GANFORT® PF in the affected eye(s) once daily, administered either in the morning or in the evening. It should be administered at the same time each day.

Existing literature data for GANFORT® suggest that evening dosing may be more effective in IOP lowering than morning dosing. However, consideration should be given to the likelihood of compliance when considering either morning or evening dosing.

In order to minimise systemic absorption of GANFORT® PF eye drops, apply pressure to the tear duct for at least 2 minutes immediately following administration of the drug (See Precautions – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information).

If more than one topical ophthalmic medicinal product is to be used, each one should be instilled at least 5 minutes apart.

The unit dose container is for single use only; one container is sufficient to treat both eyes. Any unused solution should be discarded immediately after use. If one dose is missed, treatment should continue with the next dose as planned. The dose should not exceed one drop in the affected eye(s) daily.

Contraindications

CONTRAINDICATIONS

  • Hypersensitivity to the active substances or to any of the excipients.

  • Reactive airway disease including bronchial asthma or a history of bronchial asthma, severe chronic obstructive pulmonary disease.

  • Sinus bradycardia, sick sinus syndrome, sino‐atrial nodal block, second or third degree atrioventricular block not controlled with a pacemaker; overt cardiac failure, cardiogenic shock.